Clinical Trial Update: Exploring Biomarkers in Hereditary Transthyretin Amyloidosis [NA]

View source ↗

Summary

A study investigating biomarkers in hereditary transthyretin amyloidosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin Amyloidosis

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Hereditary Transthyretin Amyloidosis | NA | Status: RECRUITING